232.01
-3.94 (-1.67%)
Previous Close | 235.95 |
Open | 233.23 |
Volume | 202,294 |
Avg. Volume (3M) | 101,293 |
Market Cap | 1,780,528,256 |
Price / Earnings (TTM) | 30.57 |
Price / Sales | 3.38 |
Price / Book | 4.91 |
52 Weeks Range | |
Earnings Date | 29 Apr 2025 - 5 May 2025 |
Profit Margin | 11.69% |
Operating Margin (TTM) | 16.27% |
Diluted EPS (TTM) | 7.59 |
Quarterly Revenue Growth (YOY) | 41.90% |
Quarterly Earnings Growth (YOY) | 41.10% |
Total Debt/Equity (MRQ) | 60.11% |
Current Ratio (MRQ) | 2.56 |
Operating Cash Flow (TTM) | 66.59 M |
Levered Free Cash Flow (TTM) | 26.12 M |
Return on Assets (TTM) | 10.22% |
Return on Equity (TTM) | 18.76% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Devices (US) | Mixed | Mixed |
Medical Devices (Global) | Mixed | Mixed | |
Stock | UFP Technologies, Inc. | Mixed | Bullish |
AIStockmoo Score
Analyst Consensus | NA |
Insider Activity | -4.0 |
Price Volatility | 4.5 |
Technical Moving Averages | 0.0 |
Technical Oscillators | -2.5 |
Average | -0.50 |
UFP Technologies Inc is a designer and custom manufacturer of components, subassemblies, products and packaging utilizing specialized foams, films, and plastics for the medical market. The company manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging. |
|
Sector | Healthcare |
Industry | Medical Devices |
Investment Style | Small Growth |
% Held by Insiders | 5.72% |
% Held by Institutions | 104.66% |
No data within this time range.
Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
---|---|---|---|---|
BAILLY R JEFFREY | - | 215.24 | -9,805 | -2,110,428 |
CARDIN STEVE | - | 215.24 | -623 | -134,095 |
CROTEAU DANIEL C | - | 232.01 | -6,846 | -1,588,340 |
FELDMANN CYNTHIA L | - | 227.59 | -2,756 | -627,238 |
HOLT JASON | - | 215.24 | -462 | -99,441 |
LATAILLE RONALD J | 232.01 | 215.24 | -1,634 | -344,994 |
LITTERIO CHRISTOPHER P. | - | 215.24 | -921 | -198,236 |
ROCK MITCHELL | - | 215.24 | -2,523 | -543,051 |
Aggregate Net Quantity | -25,570 | |||
Aggregate Net Value ($) | -5,645,823 | |||
Aggregate Avg. Buy ($) | 232.01 | |||
Aggregate Avg. Sell ($) | 218.88 |
Name | Holder | Date | Type | Quantity | Price | Value ($) |
---|---|---|---|---|---|---|
BAILLY R JEFFREY | Officer | 03 Mar 2025 | Disposed (-) | 9,805 | 215.24 | 2,110,428 |
LATAILLE RONALD J | Officer | 03 Mar 2025 | Disposed (-) | 2,034 | 215.24 | 437,798 |
ROCK MITCHELL | Officer | 03 Mar 2025 | Disposed (-) | 2,523 | 215.24 | 543,051 |
LITTERIO CHRISTOPHER P. | Officer | 03 Mar 2025 | Disposed (-) | 921 | 215.24 | 198,236 |
CARDIN STEVE | Officer | 03 Mar 2025 | Disposed (-) | 623 | 215.24 | 134,095 |
HOLT JASON | Officer | 03 Mar 2025 | Disposed (-) | 462 | 215.24 | 99,441 |
FELDMANN CYNTHIA L | Director | 28 Feb 2025 | Sell (-) | 2,756 | 227.59 | 627,238 |
FELDMANN CYNTHIA L | Director | 28 Feb 2025 | Option execute | 2,756 | - | - |
LATAILLE RONALD J | Officer | 27 Feb 2025 | Buy (+) | 400 | 232.01 | 92,804 |
CROTEAU DANIEL C | Director | 27 Feb 2025 | Sell (-) | 6,846 | 232.01 | 1,588,340 |
Date | Type | Details |
---|---|---|
25 Feb 2025 | Announcement | UFP Technologies Announces Record 2024 Results |
19 Feb 2025 | Announcement | UFP Technologies to Report Fourth Quarter and Year-end 2024 Results on February 25, 2025 |
10 Jan 2025 | Announcement | UFP Technologies to Present and Host 1X1 Investor Meetings at the CJS Securities 25th Annual “New Ideas for the New Year” Virtual Conference |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |